Wells Fargo’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.69M | Sell |
|
|||||
|
2025
Q1 | $2.39M | Sell |
|
|||||
|
2024
Q4 | $2.36M | Buy |
|
|||||
|
2024
Q3 | $2.74M | Sell |
|
|||||
|
2024
Q2 | $3.62M | Buy |
|
|||||
|
2024
Q1 | $3.18M | Sell |
|
|||||
|
2023
Q4 | $3.29M | Buy |
|
|||||
|
2023
Q3 | $3.03M | Sell |
|
|||||
|
2023
Q2 | $4.42M | Buy |
|
|||||
|
2023
Q1 | $3.91M | Buy |
|
|||||
|
2022
Q4 | $3.45M | Sell |
|
|||||
|
2022
Q3 | $3.27M | Buy |
|
|||||
|
2022
Q2 | $3.2M | Buy |
|
|||||
|
2022
Q1 | $2.21M | Buy |
|
|||||
|
2021
Q4 | $1.63M | Buy |
|
|||||
|
2021
Q3 | $2.26M | Buy |
|
|||||
|
2021
Q2 | $304K | Buy |
|
|||||
|
2021
Q1 | $83K | Sell |
|
|||||
|
2020
Q4 | $613K | Buy |
|
|||||
|
2020
Q3 | $547K | Sell |
|
|||||
|
2020
Q2 | $859K | Buy |
|
|||||
|
2020
Q1 | $218K | Buy |
|
|||||
|
2019
Q4 | $351K | Buy |
|
|||||
|
2019
Q3 | $233K | Buy |
|
|||||
|
2019
Q2 | $300K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $653K | Sell |
|
|||||
|
2018
Q3 | $859K | Sell |
|
|||||
|
2018
Q2 | $939K | Buy |
|
|||||
|
2018
Q1 | $49K | Buy |
|